| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |